Chimerix Analyst Ratings
Chimerix Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/16/2023 | 1057.89% | HC Wainwright & Co. | $11 → $11 | Reiterates | Buy → Buy |
| 08/04/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/23/2023 | 636.84% | Baird | → $7 | Initiates Coverage On | → Outperform |
| 05/05/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 03/03/2023 | 1057.89% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 09/07/2022 | 636.84% | Capital One | → $7 | Initiates Coverage On | → Overweight |
| 05/17/2022 | 1057.89% | HC Wainwright & Co. | $24 → $11 | Maintains | Buy |
| 12/22/2021 | 2426.32% | HC Wainwright & Co. | $21 → $24 | Maintains | Buy |
| 11/22/2021 | 2110.53% | HC Wainwright & Co. | $19 → $21 | Maintains | Buy |
| 06/07/2021 | 1900% | HC Wainwright & Co. | $18 → $19 | Maintains | Buy |
| 05/06/2021 | 1794.74% | HC Wainwright & Co. | $16 → $18 | Maintains | Buy |
| 04/29/2021 | 2005.26% | Maxim Group | → $20 | Initiates Coverage On | → Buy |
| 03/31/2021 | 2110.53% | Jefferies | → $21 | Initiates Coverage On | → Buy |
| 03/31/2021 | 1373.68% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 01/11/2021 | 1584.21% | HC Wainwright & Co. | $7 → $16 | Maintains | Buy |
| 03/06/2019 | 110.53% | Citigroup | $4.25 → $2 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/16/2023 | 1057.89% | HC Wainwright公司 | $11→$11 | 重申 | 购买→购买 |
| 08/04/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | 购买→购买 |
| 2023年05月23日 | 636.84% | 贝尔德 | →$7 | 开始承保 | →跑赢大盘 |
| 05/05/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | →购买 |
| 03/03/2023 | 1057.89% | HC Wainwright公司 | →$11 | 重申 | →购买 |
| 09/07/2022 | 636.84% | 大写一 | →$7 | 开始承保 | →超重 |
| 2022/05/17 | 1057.89% | HC Wainwright公司 | $24→$11 | 维护 | 买 |
| 2021年12月22日 | 2426.32% | HC Wainwright公司 | $21→$24 | 维护 | 买 |
| 2021年11月22日 | 2110.53% | HC Wainwright公司 | $19→$21 | 维护 | 买 |
| 06/07/2021 | 1900% | HC Wainwright公司 | $18→$19 | 维护 | 买 |
| 05/06/2021 | 1794.74% | HC Wainwright公司 | $16→$18 | 维护 | 买 |
| 04/29/2021 | 2005.26% | Maxim集团 | →$20 | 开始承保 | →购买 |
| 03/31/2021 | 2110.53% | 杰富瑞 | →$21 | 开始承保 | →购买 |
| 03/31/2021 | 1373.68% | 韦德布什 | →$14 | 开始承保 | →跑赢大盘 |
| 2021/11/01 | 1584.21% | HC Wainwright公司 | $7→$16 | 维护 | 买 |
| 2019年03月06日 | 110.53% | 花旗集团 | $4.25→$2 | 维护 | 中性 |
What is the target price for Chimerix (CMRX)?
Chimerix(CMRX)的目标价是多少？
The latest price target for Chimerix (NASDAQ: CMRX) was reported by HC Wainwright & Co. on August 16, 2023. The analyst firm set a price target for $11.00 expecting CMRX to rise to within 12 months (a possible 1057.89% upside). 6 analyst firms have reported ratings in the last year.
纳斯达克(JD：CMRX)的最新目标价是由HC Wainwright&Co.于2023年8月16日报道的。这家分析公司将目标价定为11美元，预计CMRX将在12个月内升至(可能上涨1057.89)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Chimerix (CMRX)?
Chimerix(CMRX)的最新分析师评级是多少？
The latest analyst rating for Chimerix (NASDAQ: CMRX) was provided by HC Wainwright & Co., and Chimerix reiterated their buy rating.
分析师对奇美力士(纳斯达克代码：CMRX)的最新评级由HC Wainwright&Co.提供，奇美力士重申其买入评级。
When is the next analyst rating going to be posted or updated for Chimerix (CMRX)?
Chimerix(CMRX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimerix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimerix was filed on August 16, 2023 so you should expect the next rating to be made available sometime around August 16, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Chimerix的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Chimerix的上一次评级是在2023年8月16日提交的，所以你应该预计下一次评级将在2024年8月16日左右提供。
Is the Analyst Rating Chimerix (CMRX) correct?
分析师评级Chimerix(CMRX)正确吗？
While ratings are subjective and will change, the latest Chimerix (CMRX) rating was a reiterated with a price target of $11.00 to $11.00. The current price Chimerix (CMRX) is trading at is $0.95, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Chimerix(CMRX)评级被重申，目标价在11.00美元至11.00美元之间。Chimerix(CMRX)目前的交易价格为0.95美元，超出了分析师的预测区间。